Anti-Natalizumab Antibody

Understand what Anti-Natalizumab Antibody signals

Primary unit: ng/mL
LOINC codes: 103631-8
Commercial laboratory assays: 1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for Anti-Natalizumab Antibody

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Natalizumab and Anti-Natalizumab Antibody, Dose ASSURE™ NTZ

Laboratory: Labcorp
Test code: 505510
Specimen: Serum
Fasting: Not stated
LOINC: 103631-8
Turnaround: 10 - 14 days

Laboratory assay overview

This test provides natalizumab drug and anti-natalizumab antibody concentrations for pharmacokinetic and immunogenic assessment to optimize treatment. This test may be helpful in any patient on natalizumab therapy for multiple sclerosis, Crohn's disease or other conditions. In the presence of anti-natalizumab antibodies, the natalizumab level reflects the free antibody-unbound drug level. This anti-natalizumab antibody assay is drug tolerant.

Labcorp test directory, test code 505510

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.